688 related articles for article (PubMed ID: 25659810)
1. SHOX gene variants: growth hormone/insulin-like growth factor-1 status and response to growth hormone treatment.
Shapiro S; Klein GW; Klein ML; Wallach EJ; Fen Y; Godbold JH; Rapaport R
Horm Res Paediatr; 2015; 83(1):26-35. PubMed ID: 25659810
[TBL] [Abstract][Full Text] [Related]
2. Impaired GH secretion in patients with SHOX deficiency and efficacy of recombinant human GH therapy.
Iughetti L; Vannelli S; Street ME; Pirazzoli P; Bertelloni S; Radetti G; Capone L; Stasiowska B; Mazzanti L; Gastaldi R; Maggio MC; Predieri B
Horm Res Paediatr; 2012; 78(5-6):279-87. PubMed ID: 23208451
[TBL] [Abstract][Full Text] [Related]
3. The growth response to GH treatment is greater in patients with SHOX enhancer deletions compared to SHOX defects.
Donze SH; Meijer CR; Kant SG; Zandwijken GR; van der Hout AH; van Spaendonk RM; van den Ouweland AM; Wit JM; Losekoot M; Oostdijk W
Eur J Endocrinol; 2015 Nov; 173(5):611-21. PubMed ID: 26264720
[TBL] [Abstract][Full Text] [Related]
4. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
[TBL] [Abstract][Full Text] [Related]
5. The insulin-like growth factor-I response to growth hormone is increased in prepubertal children with obesity and tall stature.
Bouhours-Nouet N; Gatelais F; Boux de Casson F; Rouleau S; Coutant R
J Clin Endocrinol Metab; 2007 Feb; 92(2):629-35. PubMed ID: 17090643
[TBL] [Abstract][Full Text] [Related]
6. Identification of short stature caused by SHOX defects and therapeutic effect of recombinant human growth hormone.
Binder G; Schwarze CP; Ranke MB
J Clin Endocrinol Metab; 2000 Jan; 85(1):245-9. PubMed ID: 10634394
[TBL] [Abstract][Full Text] [Related]
7. Variable degree of growth hormone (GH) and insulin-like growth factor (IGF) sensitivity in children with idiopathic short stature compared with GH-deficient patients: evidence from an IGF-based dosing study of short children.
Cohen P; Germak J; Rogol AD; Weng W; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2010 May; 95(5):2089-98. PubMed ID: 20207829
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone is effective in treatment of short stature associated with short stature homeobox-containing gene deficiency: Two-year results of a randomized, controlled, multicenter trial.
Blum WF; Crowe BJ; Quigley CA; Jung H; Cao D; Ross JL; Braun L; Rappold G;
J Clin Endocrinol Metab; 2007 Jan; 92(1):219-28. PubMed ID: 17047016
[TBL] [Abstract][Full Text] [Related]
9. Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.
Bannink EM; van Doorn J; Mulder PG; Hokken-Koelega AC
J Clin Endocrinol Metab; 2007 Aug; 92(8):2992-3000. PubMed ID: 17504895
[TBL] [Abstract][Full Text] [Related]
10. Significant increase of IGF-I concentration and of IGF-I/IGFBP-3 molar ratio in generation test predicts the good response to growth hormone (GH) therapy in children with short stature and normal results of GH stimulating tests.
Smyczynska J; Hilczer M; Stawerska R; Lewinski A
Neuro Endocrinol Lett; 2013; 34(3):222-8. PubMed ID: 23685421
[TBL] [Abstract][Full Text] [Related]
11. Etiology of short stature in Indian children and an assessment of the growth hormone-insulin-like growth factor axis in children with idiopathic short stature.
Kumar A; Pal A; Kalaivani M; Gupta N; Jain V
J Pediatr Endocrinol Metab; 2018 Sep; 31(9):1009-1017. PubMed ID: 30130251
[TBL] [Abstract][Full Text] [Related]
12. Circulating IGF-I, IGFBP-3 and the IGF-I/IGFBP-3 Molar Ratio Concentration and Height Outcome in Prepubertal Short Children on rhGH Treatment over Two Years of Therapy.
Ballerini MG; Braslavsky D; Scaglia PA; Keselman A; Rodríguez ME; Martínez A; Freire AV; Domené HM; Jasper HG; Bergadá I; Ropelato MG
Horm Res Paediatr; 2017; 88(5):354-363. PubMed ID: 28926833
[TBL] [Abstract][Full Text] [Related]
13. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
14. Safety Outcomes and Near-Adult Height Gain of Growth Hormone-Treated Children with SHOX Deficiency: Data from an Observational Study and a Clinical Trial.
Benabbad I; Rosilio M; Child CJ; Carel JC; Ross JL; Deal CL; Drop SL; Zimmermann AG; Jia N; Quigley CA; Blum WF
Horm Res Paediatr; 2017; 87(1):42-50. PubMed ID: 28002818
[TBL] [Abstract][Full Text] [Related]
15. Growth response to growth hormone treatment in patients with SHOX deficiency can be predicted by the Cologne prediction model.
Hoyer-Kuhn H; Franklin J; Jones C; Blum WF; Schoenau E
J Pediatr Endocrinol Metab; 2018 Jan; 31(1):25-31. PubMed ID: 29197219
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Safety and Efficacy of Growth Hormone Therapy by IGF-1 Z Score in Children with Short Stature.
Liu HJ; Wang LH; Chen L
Adv Ther; 2019 Sep; 36(9):2374-2383. PubMed ID: 31301056
[TBL] [Abstract][Full Text] [Related]
17. Elevated insulin-like growth factor-I values in children with Prader-Willi syndrome compared with growth hormone (GH) deficiency children over two years of GH treatment.
Feigerlová E; Diene G; Oliver I; Gennero I; Salles JP; Arnaud C; Tauber M
J Clin Endocrinol Metab; 2010 Oct; 95(10):4600-8. PubMed ID: 20926543
[TBL] [Abstract][Full Text] [Related]
18. Secondary IGF-I deficiency as a prognostic factor of growth hormone (GH) therapy effectiveness in children with isolated, non-acquired GH deficiency.
Smyczyńska J; Stawerska R; Hilczer M; Lewiński A
Exp Clin Endocrinol Diabetes; 2015 Apr; 123(4):209-14. PubMed ID: 25607339
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness of the combined recombinant human growth hormone and gonadotropin-releasing hormone analog therapy in pubertal patients with short stature due to SHOX deficiency.
Scalco RC; Melo SS; Pugliese-Pires PN; Funari MF; Nishi MY; Arnhold IJ; Mendonca BB; Jorge AA
J Clin Endocrinol Metab; 2010 Jan; 95(1):328-32. PubMed ID: 19926713
[TBL] [Abstract][Full Text] [Related]
20. Insulin growth factor-based dosing of growth hormone therapy in children: a randomized, controlled study.
Cohen P; Rogol AD; Howard CP; Bright GM; Kappelgaard AM; Rosenfeld RG;
J Clin Endocrinol Metab; 2007 Jul; 92(7):2480-6. PubMed ID: 17356043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
